Vagus Nerve Stimulation Improves Headache, Migraine PainApril 27th 2018
A non-invasive vagus nerve stimulation therapy significantly improved pain-free rates compared with a sham device for patients with episodic cluster headache and migraines.
Lilyana Amezcua, MD: Better Understanding MS in the Hispanic CommunityApril 26th 2018
The associate professor of clinical neurology spoke about the need to understand modifiable social and cultural factors that could impact disease severity and progression.
Gregory Day, MD, MSc: The Challenge of Alzheimer DiagnosisApril 26th 2018
The clinical director of the Anti-NMDA Receptor Encephalitis Foundation spoke about the insidiousness of AD and the need for diagnosis earlier in disease progression.
Alberto Espay, MD, MSc: Modifying Thought About Parkinson DiseaseApril 25th 2018
The UC Health professor of neurology argued that with the current view on Parkinson disease, the field is missing the mark for disease-modifying interventions.
Ralph Kern, MD, MHSc: The State of Therapies for ALSApril 25th 2018
The chief medical officer and chief operating officer of Brainstorm Cell Therapeutics spoke about a host of topics related to the treatment of amyotrophic lateral sclerosis.
IncobotulinumtoxinA Successful in Treating Sialorrhea in Parkinson, Other Neurological ConditionsApril 24th 2018
Study findings revealed statistically significant results at week 4 for the 100-U dose compared to placebo. The 75-U dose, while effective, did not achieve statistical significance.
Siponimod Reduces Disability Progression in Secondary Progressive Multiple SclerosisApril 21st 2018
The data from the phase III EXPAND study indicated to the researchers that this risk reduction obtained with siponimod was substantially isolated from MS relapse.